We assessed 72 consecutive patients with a diagnosis of metastatic colorectal cancer (mCRC) using IdyllaTM Biocartis, a fully automated platform that evaluates the most frequent mutations of KRAS, NRAS and BRAF genes. The gene discussed is NRAS; the disease is metastatic colorectal cancer.